Current State of Left Atrial Appendage Closure

Efficacy and safety of left atrial appendage closure with WATCHMAN in patients with or without contraindication to oral anticoagulation: 1-Year follow-up outcome data of the EWOLUTION trial

(2017) Lucas V. Boersma et al.   HEART RHYTHM

Assessing the Safety of Early U.S. Commercial Application of Left Atrial Appendage Closure ∗

(2017) Jacqueline Saw et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Post-Approval U.S. Experience With Left Atrial Appendage Closure for Stroke Prevention in Atrial Fibrillation

(2017) Vivek Y. Reddy et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Influence of Direct Oral Anticoagulants on Rates of Oral Anticoagulation for Atrial Fibrillation

(2017) Lucas N. Marzec et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Clinical Implications of Leaks Following Left Atrial Appendage Ligation With the LARIAT Device

(2016) Carola Gianni et al.   JACC-Cardiovascular Interventions

Bleeding Outcomes After Left Atrial Appendage Closure Compared With Long-Term Warfarin

(2015) Matthew J. Price et al.   JACC-Cardiovascular Interventions

Left Atrial Appendage Closure to Prevent Stroke in Patients With Atrial Fibrillation

(2014) Matthew J. Price et al.   CIRCULATION

Percutaneous Left Atrial Appendage Closure vs Warfarin for Atrial Fibrillation

(2014) Vivek Y. Reddy et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary

(2014) Craig T. January et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Early Safety and Efficacy of Percutaneous Left Atrial Appendage Suture Ligation

(2014) Matthew J. Price et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Comparative Effectiveness of Warfarin and New Oral Anticoagulants for the Management of Atrial Fibrillation and Venous Thromboembolism

(2013) Soheir S. Adam et al.   ANNALS OF INTERNAL MEDICINE

Percutaneous management of late leak after lariat transcatheter ligation of the left atrial appendage in patients with atrial fibrillation at high risk for stroke

(2013) William J. Mosley et al.   CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS

Worldwide Epidemiology of Atrial Fibrillation

(2013) Sumeet S. Chugh et al.   CIRCULATION

Left Atrial Appendage Closure With the Watchman Device in Patients With a Contraindication for Oral Anticoagulation

(2013) Vivek Y. Reddy et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Edoxaban versus Warfarin in Patients with Atrial Fibrillation

(2013) Robert P. Giugliano et al.   NEW ENGLAND JOURNAL OF MEDICINE

Apixaban versus Warfarin in Patients with Atrial Fibrillation

(2011) Christopher B. Granger et al.   NEW ENGLAND JOURNAL OF MEDICINE

Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation

(2011) Manesh R. Patel et al.   NEW ENGLAND JOURNAL OF MEDICINE

A Novel User-Friendly Score (HAS-BLED) To Assess 1-Year Risk of Major Bleeding in Patients With Atrial Fibrillation

(2010) Ron Pisters et al.   CHEST

Risk of bleeding in patients with acute myocardial infarction treated with different combinations of aspirin, clopidogrel, and vitamin K antagonists in Denmark: a retrospective analysis of nationwide registry data

(2009) Rikke Sørensen et al.   LANCET

Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial

(2009) David R Holmes et al.   LANCET

Dabigatran versus Warfarin in Patients with Atrial Fibrillation

(2009) Stuart J. Connolly et al.   NEW ENGLAND JOURNAL OF MEDICINE

Hemorrhagic Complications of Anticoagulant and Thrombolytic Treatment

(2008) Sam Schulman et al.   CHEST